Multicenter Phase 2 Trial of Ramucirumab Plus Irinotecan in Patients with Early Relapsed Gastric Cancer During or After Adjuvant Docetaxel Plus S-1 Therapy: RAMIEL Trial (OGSG1901)

Ryohei Kawabata, Toshifumi Yamaguchi, Yusuke Akamaru, Hidekazu Hirano, Keijiro Sugimura, Masaaki Motoori, Yoshihiro Kakeji, Yosuke Kito, Takashi Nomura, Takeshi Kawakami, Masahiro Tanemura, Atsushi Takeno, Hiroyuki Okuda, Tomohiro Matsushima, Toshio Shimokawa, Yukinori Kurokawa, Shunji Endo, Narikazu Boku, Taroh Satoh

ESMO 2025, Berlin, Germany 17 – 21 Oct 2025

Warning: Trying to access array offset on false in /home/grwdev/grwdev.works/public_html/ogsg2026.grwdev.works/wp/wp-content/themes/OGSG/single.php on line 62